Bharat Biotech's Covaxin Approval Requested In US For Children Below 18

https://ift.tt/eA8V8J
US company Ocugen announced Friday that it had asked authorities for emergency use authorization for Covid-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.

from November 06, 2021 at 08:07AM
NDTV News - Topstories https://ift.tt/3bIUCMT